JP2010500303A5 - - Google Patents

Download PDF

Info

Publication number
JP2010500303A5
JP2010500303A5 JP2009523181A JP2009523181A JP2010500303A5 JP 2010500303 A5 JP2010500303 A5 JP 2010500303A5 JP 2009523181 A JP2009523181 A JP 2009523181A JP 2009523181 A JP2009523181 A JP 2009523181A JP 2010500303 A5 JP2010500303 A5 JP 2010500303A5
Authority
JP
Japan
Prior art keywords
casein
resveratrol
complex
complex according
composite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009523181A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010500303A (ja
JP5493189B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/006821 external-priority patent/WO2008017415A1/en
Publication of JP2010500303A publication Critical patent/JP2010500303A/ja
Publication of JP2010500303A5 publication Critical patent/JP2010500303A5/ja
Application granted granted Critical
Publication of JP5493189B2 publication Critical patent/JP5493189B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009523181A 2006-08-09 2007-08-02 カゼイン複合体 Expired - Fee Related JP5493189B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06016660.0 2006-08-09
EP06016660 2006-08-09
PCT/EP2007/006821 WO2008017415A1 (en) 2006-08-09 2007-08-02 Casein complexes

Publications (3)

Publication Number Publication Date
JP2010500303A JP2010500303A (ja) 2010-01-07
JP2010500303A5 true JP2010500303A5 (enExample) 2014-01-30
JP5493189B2 JP5493189B2 (ja) 2014-05-14

Family

ID=37460260

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009523181A Expired - Fee Related JP5493189B2 (ja) 2006-08-09 2007-08-02 カゼイン複合体

Country Status (8)

Country Link
US (1) US8642736B2 (enExample)
EP (1) EP2049091B1 (enExample)
JP (1) JP5493189B2 (enExample)
CN (1) CN101500549A (enExample)
AT (1) ATE493122T1 (enExample)
DE (1) DE602007011627D1 (enExample)
ES (1) ES2358367T3 (enExample)
WO (1) WO2008017415A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008088123A (ja) * 2006-10-03 2008-04-17 Oriza Yuka Kk 美肌用組成物
JP2008255020A (ja) * 2007-04-02 2008-10-23 Fujifilm Corp 抗老化皮膚外用剤
US20110129590A1 (en) * 2009-05-27 2011-06-02 Kathryn Deibler Beverage Product with Resveratrol
JP2011046660A (ja) * 2009-08-28 2011-03-10 Fujifilm Corp マトリックスメタロプロテアーゼ−2(mmp−2)阻害剤
JP5820115B2 (ja) * 2010-01-14 2015-11-24 武義 浦田 経口摂取用組成物
US20120070475A1 (en) * 2010-03-11 2012-03-22 Pepsico, Inc Zero Calorie Polyphenol Aqueous Dispersions
US20110223256A1 (en) * 2010-03-11 2011-09-15 Stokely-Van Camp, Inc. Method For Stabilizing Flavonoid Aqueous Dispersion
WO2012043680A1 (ja) * 2010-09-29 2012-04-05 富士フイルム株式会社 水系皮膚外用剤
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
EP2968070B1 (en) * 2013-03-15 2019-12-18 Glanbia Nutritionals (Ireland) Ltd. Method for improving bioavailability of therapeutic compounds
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
CN103859423A (zh) * 2014-04-09 2014-06-18 青岛博之源生物技术有限公司 一种抗癌的花生蛋白粉及制备方法
US10983119B2 (en) * 2016-01-25 2021-04-20 General Electric Company Device for rapid diagnostic tests to detect antigens with improved sensitivity
CN112126519B (zh) * 2020-09-16 2022-04-29 江南大学 一种制备共包埋双重抗氧化剂的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2820975B1 (fr) * 2001-02-21 2004-03-12 Oreal Composition pour application topique comprenant au moins un hydroxystilbene et au moins un polyol pour solubiliser l'hydroxystilbene
ITMI20010528A1 (it) * 2001-03-13 2002-09-13 Istituto Biochimico Pavese Pha Complessi di resveratrolo con fosfolipidi loro preparazione e composizioni farmaceutiche e cosmetiche
ES2190771B2 (es) * 2002-01-24 2004-03-01 Univ Alicante Procedimiento para la produccion de resveratrol en cultivos celulares.
DE60319727T2 (de) * 2002-10-21 2009-03-12 L'oreal Verfahren zum auflösen lipophiler verbindungen, und kosmetische zusammensetzung.
JP2006528239A (ja) 2003-05-26 2006-12-14 エンプラニ シーオー.,エルティーディ. レスベラトロルを含有する、美白及び抗酸化作用を有する化粧料組成物、並びに、その製造方法
CA2649788A1 (en) * 2006-04-20 2007-11-01 Technion Research And Development Foundation Ltd. Casein micelles for nanoencapsulation of hydrophobic compounds

Similar Documents

Publication Publication Date Title
JP2010500303A5 (enExample)
Khalil et al. Biosynthesis of Au nanoparticles using olive leaf extract: 1st nano updates
IL255113B (en) Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US10780115B2 (en) Preparation of antimicrobial agent based on ZnO/GQD-PEI composites
WO2008149788A1 (ja) 固形透析用剤
WO2012051426A3 (en) Aggregate nanoparticulate medicament formulations, manufacture and use thereof
WO2010117199A3 (ko) 코엔자임 q10 나노입자, 그 제조방법 및 상기 나노입자를 포함하는 조성물
WO2010053335A2 (ko) 난용성 약물의 나노입자를 포함하는 분말의 제조방법, 그에 의해 제조된 분말 및 이를 포함하는 약학적 조성물
EP1844884A4 (en) SILVER PARTICLE POWDER AND PROCESS FOR PRODUCING THE SAME
WO2005038948A3 (en) Nanosized silver oxide powder
CN109310622A (zh) 尼古丁颗粒和组合物
WO2009142852A3 (en) Process for manufacturing flowable powder drug compositions
US20150004286A1 (en) Method of instantizing amino acids
Mohammadinejad et al. Synthesis of silver nanoparticles using Silybum marianum seed extract
MX348866B (es) Producto de bicarbonato de sodio.
JP2013502909A5 (enExample)
WO2011152532A1 (ja) 安定性が向上したカシューナッツ殻油
WO2012058668A3 (en) Ternary mixture formulations
JP2009195198A (ja) クルクミン分散液
CN103637984A (zh) 一种黄芩苷纳米结晶及其制备方法
Raut et al. Sustainable Antimicrobial Nanomaterials: A Promising Treatment for Multiple Drug Resistant Microorganisms
Liu et al. Yeast‐Controlled Double‐Shelled CaCO3/CaF2 Hollow Nanospheres with Hierarchically Porous for Sustained pH‐Sensitive Drug Release
CN103585186A (zh) 蛹虫草纳米全粉速溶冲剂及其生产方法
Lynch et al. Subchronic and reproductive toxicity of whole dried Hoodia parviflora aerial parts in the rat
JP2004357532A (ja) 可食性乳化剤含有造粒粉末及び該粉末の製造方法